BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, January 18, 2026
Home » Authors » Mark McCarty

Articles by Mark McCarty

MDD Perspectives: My top five reasons to detest CPAP machines

Aug. 29, 2011
By Mark McCarty

Washington roundup: EC updates guidance on medical device classifications, categories

Aug. 29, 2011
By Mark McCarty

Top Five Reasons to Hate CPAP Machines

Aug. 26, 2011
By Mark McCarty
CPAP. Such an innocent-seeming acronym, no? It stands for continuous positive airway pressure, which also comes across as pretty harmless. I use one of those things, though, and I have to tell you something. They're a colossal pain in the you-know-what. The only thing worse than a CPAP machine strapped to your face is obstructive sleep apnea (which I have) or central sleep apnea (which I don't as far as I know). Here's the deal. You strap one of these masks over your face – over your nose in this case – and it blows air past the obstruction...
Read More

HHS trumpets bundled payment initiative; some say 'capitation'

Aug. 26, 2011
By Mark McCarty

On This Date in History

Aug. 25, 2011
By Mark McCarty
On This Date: The birth of Emil Theodor Kocher, MD, Swiss surgical pioneer With the pace of change in the modern world and the emphasis on what's just around the corner, it can be edifying to take a moment to ask where we've been. And so we reflect for a moment on the work of Emil Theodor Kocher, MD, who was born 170 years ago on this date, Aug. 25, 1841. Kocher was born in Berne, Switzerland, where he earned his medical degree in 1865. He took the position of director of surgery at the Inselspital (Island Hospital), also in...
Read More

Washington roundup: NIH announces update to '95 guidance on financial conflict

Aug. 25, 2011
By Mark McCarty

Beckman hit with warning for validation and CAPA failures

Aug. 24, 2011
By Mark McCarty

Washington roundup: Two Dems want a GAO report on insulin pump security issues

Aug. 23, 2011
By Mark McCarty

Washington roundup: CDER guidance may ramp up imaging requirements in trials

Aug. 22, 2011
By Mark McCarty

Picking your poison: Wall Street or Venture Capital?

Aug. 21, 2011
By Mark McCarty
Life is full of choices, not all of them pleasant. For device makers of late, this definitely holds true. Firms in the venture capital end of things are not necessarily worried that VC has utterly abandoned med-tech, but it would appear that the start-up might find the going tough, even though firms with a little more development are getting more love from investors. As my colleague Amanda Pedersen noted in Medical Device Daily recently, a recent report by CB Insights (New York) indicates that the number of VC deals for med-tech continues to tail off, dropping from 184 in...
Read More
Previous 1 2 … 451 452 453 454 455 456 457 458 459 … 578 579 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 16, 2026.
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

    BioWorld
    With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing